Susanne Rhoades
Associate Vice President, Diagnostic Development Eli Lilly
Seminars
Thursday 25th September 2025
Expanding Precision Medicine’s Reach: Driving Harmonized Commercialization of Drug-Diagnostics to Enable Timely, Adoptable Therapy Launch
Thursday 25th September 2025
Chair’s Opening Remarks
8:00 am
Thursday 25th September 2025
Chair’s Closing Remarks & End of 15th World Clinical Biomarkers & CDx Summit
2:50 pm
Monday 22nd September 2025
Panel Discussion: Assessing Biopharma Partnership Selection Strategies in Precision Medicine to Strengthen Strategic Partnerships & Accelerate Clinical Success
11:10 am
- What capabilities, compliance, or market experience drive appetite to collaborate with a particular vendor? And how do different pharma companies prioritize vendor selection considering these criteria?
- What is the role of cross-functional teams in efficient vendor evaluation across pharma organizations?
- What is the significance of global vendor footprint in the context of co-development and large scale manufacturing?
- How are testing decisions around centralized or decentralized testing determined in each market?
